In a global league, Canada’s biotech industry would be respectably mid table. LSIPR talks to Andrew Casey, president of industry association BIOTECanada, about how the organisation is trying to take it to the next level.
Canada’s economy was built on a vast and varied natural resource base. Today, agriculture, energy, mining and forestry still account for more than half of the country’s exports. While the balance of the economy is changing over time, away from the big traditional industries and towards other sectors, it is still the case that much of Canada’s wealth comes from its land or what grows on it.
For BIOTECanada, the industry association representing the country’s biotechnology industry, the challenge is promoting a different kind of natural resource. Andrew Casey, president of the association, describes the industry in Canada as “large and small companies trying to take good ideas to help other industries transform.”
The association has three main focuses: health, of course, and then industrial and agricultural. These last two play an important role in Canada’s economy, and Casey is keen to highlight some of the contributions made by biotechnology companies to those sectors. For example, one association member has developed a process to extract from mustard seeds a substance that can be used as jet fuel. Emissions are significantly reduced, and the by-product can be used for animal feed. Another example is a company that has developed an enzyme to “gobble up CO2 emissions from the oil and gas sector,” Casey says.
Life Sciences Intellectual Property Review (LSIPR) tracks the increasing challenges for intellectual property specialists in the rapidly evolving world of life sciences. From gene patents to stem cell research, we provide the very best news and analysis.
To continue reading this article and to access 4,500+ articles, our digital magazines and special reports published for LSIPR subscribers only then you will need a subscription.
If you are already subscribed please login.
Official LSIPR subscribers include:
Allen & Overy
Arnold & Siedsma
Birch, Stewart, Kolasch & Birch LLP (BSKB)
Carpmaels & Ransford
Cooley
European Patent Office
Finnegan LLP
GH Research
Gowling WLG
George Washington Law School
HGF Limited
IQVIA
Kirkland & Ellis International LLP
Marks & Clerk
Mintz Levin
NiKang Therapeutics Inc.
Powell Gilbert LLP
Procopio, Cory, Hargreaves & Savitch LLP
Taylor Wessing
The United States Patent and Trademark Office (USPTO)
Valea AB
World Intellectual Property Office
For multi-user price options, or to check if your company has an existing subscription we can add you into for FREE, please contact Atif at achoudhury@newtonmedia.co.
If you have any technical issues please email tech support.
BIOTECanada, Andrew Casey, association focus, Canadian biotech